Antibiotic Utilization Patterns in Patients with Ventilator-Associated Pneumonia: A Canadian Context

Table 5

Duration of therapy according to microbiology.

	All cases	Group I	Group II
Duration of antibiotics: days,; median (IQR)	10.0 (7, 14)	10.0 (7, 15)	13.0 (11, 13.5)
Difference		3.0
Proportion of cases with antibiotic durations of; ( (%))
<7 days		17 (16.5)
7–10 days		39 (37.9)
>10 days		47 (45.6)
<13 days			3 (37.5)
13–15 days			4 (50)
>15 days			1 (12.5)

Out of 200 VAP cases, 111 grew bacterial pathogens that were further divided into Group I and Group II bacteria.
Group I: pathogens that did not include any of the Acinetobacter, Stenotrophomonas, or Pseudomonas species.
Group II: pathogens that included any of the Acinetobacter, Stenotrophomonas, or Pseudomonas species.